Venovenous extracorporeal membrane oxygenation devices-related colonisations and infections

Annals of Intensive Care

Table 2 Outcome of extracorporeal membrane oxygenation in patients without infected/colonised ECMO device, with ECMO device colonisation and ECMO device infection (at the time of ECMO removal)

Number of ECMO^a	U-I/C ED	ED-C	ED-I	p value
Number of ECMO^a	60	33	10	p value
ICU LOS	25 (14–39)	24 (20–33)	30 (23–37)	0.614
ICU mortality	27 (45)	21 (63.6)	4 (40)	0.559
Day-90 mortality	28 (46.7)	22 (66.7)	4 (40)	0.622
In-hospital mortality	32 (53.3)	22 (66.7)	6 (60)	0.896
Days of MV	23 (12–37)	24 (18–32)	28 (23–30)	0.671
VFD day 28	0 (0–1)	0 (0–0)	0 (0–0)	0.385
VFD day 90	1 (0–60)	0 (0–35)	9 (0–52)	0.506
ECMOFD day 28	13 (0–21)	3 (0–18)	7 (0–14)	0.169
ECMOFD day 90	63 (0–83)	9 (0–78)	62 (0–76)	0.156
ECMO weaning	43 (71.7)	17 (51.5)	7 (70)	0.283

Data are provided as no. (%) of ECMO or median value (interquartile range)
ECMO extracorporeal membrane oxygenation, ECMOFD ECMO-free day, ICU intensive care unit, LOS length of stay, MV mechanical ventilation, VFD ventilator-free day, U-I/C ED uninfected/uncolonised ECMO device, ED-C ECMO device colonisation, ED-I ECMO device infection
^aAmong the 99 patients, 4 underwent 2 ECMO during their ICU stay corresponding to 103 VV-ECMO